Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial.

Keefer MC, Zheng B, Rosenberg AF, Kobie JJ.

AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1143-1148.

PMID:
27612555
2.

The B-cell response to foot-and-mouth-disease virus in cattle following vaccination and live-virus challenge.

Grant CF, Carr BV, Singanallur NB, Morris J, Gubbins S, Hudelet P, Ilott M, Charreyre C, Vosloo W, Charleston B.

J Gen Virol. 2016 Sep;97(9):2201-9. doi: 10.1099/jgv.0.000517. Epub 2016 Jun 2.

PMID:
27260141
3.

ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination.

Bentebibel SE, Khurana S, Schmitt N, Kurup P, Mueller C, Obermoser G, Palucka AK, Albrecht RA, Garcia-Sastre A, Golding H, Ueno H.

Sci Rep. 2016 May 27;6:26494. doi: 10.1038/srep26494.

4.

Evaluating the case-positive, control test-negative study design for influenza vaccine effectiveness for the frailty bias.

Talbot HK, Nian H, Chen Q, Zhu Y, Edwards KM, Griffin MR.

Vaccine. 2016 Apr 4;34(15):1806-9. doi: 10.1016/j.vaccine.2016.02.037. Epub 2016 Feb 28.

PMID:
26930368
5.

Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood.

Quách TD, Rodríguez-Zhurbenko N, Hopkins TJ, Guo X, Hernández AM, Li W, Rothstein TL.

J Immunol. 2016 Feb 1;196(3):1060-9. doi: 10.4049/jimmunol.1501843. Epub 2016 Jan 6.

6.

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines.

Sridhar S, Brokstad KA, Cox RJ.

Vaccines (Basel). 2015 Apr 24;3(2):373-89. doi: 10.3390/vaccines3020373. Review.

7.

New approaches to understanding the immune response to vaccination and infection.

Furman D, Davis MM.

Vaccine. 2015 Sep 29;33(40):5271-81. doi: 10.1016/j.vaccine.2015.06.117. Epub 2015 Jul 29. Review.

8.

Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.

Halliley JL, Tipton CM, Liesveld J, Rosenberg AF, Darce J, Gregoretti IV, Popova L, Kaminiski D, Fucile CF, Albizua I, Kyu S, Chiang KY, Bradley KT, Burack R, Slifka M, Hammarlund E, Wu H, Zhao L, Walsh EE, Falsey AR, Randall TD, Cheung WC, Sanz I, Lee FE.

Immunity. 2015 Jul 21;43(1):132-45. doi: 10.1016/j.immuni.2015.06.016. Epub 2015 Jul 14.

10.

Focused antibody response to influenza linked to antigenic drift.

Huang KY, Rijal P, Schimanski L, Powell TJ, Lin TY, McCauley JW, Daniels RS, Townsend AR.

J Clin Invest. 2015 Jul 1;125(7):2631-45. doi: 10.1172/JCI81104. Epub 2015 May 26.

11.

The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.

Haralambieva IH, Painter SD, Kennedy RB, Ovsyannikova IG, Lambert ND, Goergen KM, Oberg AL, Poland GA.

PLoS One. 2015 Mar 27;10(3):e0122282. doi: 10.1371/journal.pone.0122282. eCollection 2015 Mar 27.

12.

Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.

He XS, Holmes TH, Sanyal M, Albrecht RA, García-Sastre A, Dekker CL, Davis MM, Greenberg HB.

J Infect Dis. 2015 Apr 1;211(7):1051-9. doi: 10.1093/infdis/jiu580. Epub 2014 Oct 21.

13.

Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans.

Toapanta FR, Simon JK, Barry EM, Pasetti MF, Levine MM, Kotloff KL, Sztein MB.

Front Immunol. 2014 Aug 20;5:374. doi: 10.3389/fimmu.2014.00374. eCollection 2014 Aug 20.

14.

Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody.

Kobie JJ, Treanor JJ, Ritchlin CT.

Immunol Invest. 2014;43(6):606-15. doi: 10.3109/08820139.2013.871555.

15.

Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements.

Jackson KJ, Liu Y, Roskin KM, Glanville J, Hoh RA, Seo K, Marshall EL, Gurley TC, Moody MA, Haynes BF, Walter EB, Liao HX, Albrecht RA, García-Sastre A, Chaparro-Riggers J, Rajpal A, Pons J, Simen BB, Hanczaruk B, Dekker CL, Laserson J, Koller D, Davis MM, Fire AZ, Boyd SD.

Cell Host Microbe. 2014 Jul 9;16(1):105-14. doi: 10.1016/j.chom.2014.05.013. Epub 2014 Jun 26.

16.

Polyclonal B cell activation for accurate analysis of pre-existing antigen-specific memory B cells.

Karahan GE, Eikmans M, Anholts JD, Claas FH, Heidt S.

Clin Exp Immunol. 2014 Jul;177(1):333-40. doi: 10.1111/cei.12305.

17.

Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease.

Nath KD, Burel JG, Shankar V, Pritchard AL, Towers M, Looke D, Davies JM, Upham JW.

Int J Chron Obstruct Pulmon Dis. 2014;9:51-6. doi: 10.2147/COPD.S53590. Epub 2013 Dec 24.

18.

Immunoproteomic analysis of antibody in lymphocyte supernatant in patients with typhoid fever in Bangladesh.

Charles RC, Liang L, Khanam F, Sayeed MA, Hung C, Leung DT, Baker S, Ludwig A, Harris JB, Larocque RC, Calderwood SB, Qadri F, Felgner PL, Ryan ET.

Clin Vaccine Immunol. 2014 Mar;21(3):280-5. doi: 10.1128/CVI.00661-13. Epub 2013 Dec 26.

19.

Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.

Elias SC, Choudhary P, de Cassan SC, Biswas S, Collins KA, Halstead FD, Bliss CM, Ewer KJ, Hodgson SH, Duncan CJ, Hill AV, Draper SJ.

Immunology. 2014 Apr;141(4):628-44. doi: 10.1111/imm.12226.

20.

Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation.

Buckner CM, Moir S, Ho J, Wang W, Posada JG, Kardava L, Funk EK, Nelson AK, Li Y, Chun TW, Fauci AS.

J Virol. 2013 May;87(10):5800-11. doi: 10.1128/JVI.00094-13. Epub 2013 Mar 13.

Supplemental Content

Support Center